共查询到15条相似文献,搜索用时 78 毫秒
1.
2.
3.
4.
5.
以小鼠心肌摄取^86Rb能力为指标,观察了人参Rb组皂苷对小鼠心肌营养性血流的影响。结果表明,人参Rb组皂苷25.50、100mg/kg均可明显增加心肌营养性血流(P〈0.05~0.001),其作用强度优于西洋参茎叶总皂苷。 相似文献
6.
7.
目的研究人参皂苷Rb3(G-Rb3)对实验性心肌缺血的保护作用,并与西洋参茎叶20S-原人参二醇皂苷(PQDS)进行比较。方法昆明种小鼠皮下注射异丙肾上腺素后放入盛有钠石灰的250ml广口瓶内,加盖密封后记录小鼠存活时间;Wistar大鼠舌下静脉注射垂体后叶素后观察心电图变化程度。结果 G-Rb320、40mg/kg及PQDS 50mg/kg对皮下注射异丙肾上腺素缩短小鼠在常压缺氧状态下的存活时间均具有明显对抗作用;G-Rb3 14、28mg/kg及PQDS 35mg/kg均可明显减轻垂体后叶素诱发的大鼠急性心肌缺血心电图(ST段抬高及T波高耸)变化程度。结论 G-Rb3对实验性心肌缺血具有明显保护作用,其作用强度与维拉帕米相当。 相似文献
8.
研究表明人参皂苷,尤其是稀有人参皂苷、苷元具有很强的抗肿瘤、神经保护等药理活性,通过各种方法获得稀有人参皂苷的研究越来越多。本文就利用生物转化的方法将人参皂苷转化为稀有人参皂苷、苷元的最新研究进展进行了简要的综述,并简要展望了人参皂苷生物转化研究的前景。 相似文献
9.
人参皂苷Rg1对人黑素细胞株MV3黑素合成的影响 总被引:1,自引:0,他引:1
目的:观察人参皂苷Rg1对体外培养的人黑素细胞MV3增殖、黑素合成的影响。方法:体外培养黑素细胞,给予不同浓度人参皂苷Rg1(80、40、20、10、5、2.5μg/mL)处理48h后,四甲基偶氮唑蓝法(MTT)观察人参皂苷Rg1对细胞增殖的影响,比色法测定黑素含量变化情况。结果:人参皂苷Rg1 80~10μg/mL剂量能抑制黑素细胞增殖(P<0.01),减少黑素合成(P<0.01或P<0.05),2.5μg/mL剂量则促进黑素细胞增殖,但对黑素合成作用不明显。结论:人参皂苷Rg1可抑制黑素细胞增殖,减少黑素合成,这可能是其具有美白作用的机制之一。 相似文献
10.
11.
12.
13.
高效液相色谱法测定人参提取物及其胶囊中人参皂苷Rb1的含量 总被引:5,自引:0,他引:5
目的建立一种反相高效液相色谱法测定人参提取物及其胶囊中人参皂苷Rb1含量的方法.方法采用Hypersil C18(250mm×4.6mm,5 μ m)色谱柱,乙腈-水(3070,VV)为流动相,检测波长203nm.结果线性范围为0.124~1.984mg/ml,三水平的平均回收率(%)分别为100.46、100.71和100.72,RSD(%)分别为0.18、0.72和0.48.结论本法简便、准确、可靠,可作为人参提取物及其胶囊制剂的质量控制方法. 相似文献
14.
Chitin and sepia ink hybrid hemostatic sponge (CTSH sponge), a new biomedical material, was extensively studied for its beneficial biological properties of hemostasis and stimulation of healing. However, studies examining the safety of CTSH sponge in the blood system are lacking. This experiment aimed to examine whether CTSH sponge has negative effect on blood systems of mice, which were treated with a dosage of CTSH sponge (135 mg/kg) through a laparotomy. CTSH sponge was implanted into the abdominal subcutaneous and a laparotomy was used for blood sampling from abdominal aortic. Several kinds of blood parameters were detected at different time points, which were reflected by coagulation parameters including thrombin time (TT), prothrombin time (PT), activated partial thromboplatin time (APTT), fibrinogen (FIB) and platelet factor 4 (PF4); anticoagulation parameter including antithrombin III (AT-III); fibrinolytic parameters including plasminogen (PLG), fibrin degradation product (FDP) and D-dimer; hemorheology parameters including blood viscosity (BV) and plasma viscosity (PV). Results showed that CTSH sponge has no significant effect on the blood parameters of mice. The data suggested that CTSH sponge can be applied in the field of biomedical materials and has potential possibility to be developed into clinical drugs of hemostatic agents. 相似文献